63 related articles for article (PubMed ID: 20354140)
1. Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis.
Costa B; Dettori D; Lorenzato A; Bardella C; Coltella N; Martino C; Cammarata C; Carmeliet P; Olivero M; Di Renzo MF
FASEB J; 2010 Aug; 24(8):2680-8. PubMed ID: 20354140
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a functional HGF/C-MET autocrine loop in spontaneous transformants of WB-F344 rat liver stem-like cells.
Presnell SC; Hooth MJ; Borchert KM; Coleman WB; Grisham JW; Smith GJ
Hepatology; 1998 Nov; 28(5):1253-9. PubMed ID: 9794909
[TBL] [Abstract][Full Text] [Related]
3. Cells lacking the fumarase tumor suppressor are protected from apoptosis through a hypoxia-inducible factor-independent, AMPK-dependent mechanism.
Bardella C; Olivero M; Lorenzato A; Geuna M; Adam J; O'Flaherty L; Rustin P; Tomlinson I; Pollard PJ; Di Renzo MF
Mol Cell Biol; 2012 Aug; 32(15):3081-94. PubMed ID: 22645311
[TBL] [Abstract][Full Text] [Related]
4. Beta4 integrin is a transforming molecule that unleashes Met tyrosine kinase tumorigenesis.
Bertotti A; Comoglio PM; Trusolino L
Cancer Res; 2005 Dec; 65(23):10674-9. PubMed ID: 16322210
[TBL] [Abstract][Full Text] [Related]
5. Decreased fibronectin expression in Met/HGF-mediated tumorigenesis.
Taylor GA; Jeffers M; Webb CP; Koo HM; Anver M; Sekiguchi K; Vande Woude GF
Oncogene; 1998 Sep; 17(9):1179-83. PubMed ID: 9764829
[TBL] [Abstract][Full Text] [Related]
6. Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists.
Michieli P; Basilico C; Pennacchietti S; Maffè A; Tamagnone L; Giordano S; Bardelli A; Comoglio PM
Oncogene; 1999 Sep; 18(37):5221-31. PubMed ID: 10498872
[TBL] [Abstract][Full Text] [Related]
7. c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.
Christensen JG; Burrows J; Salgia R
Cancer Lett; 2005 Jul; 225(1):1-26. PubMed ID: 15922853
[TBL] [Abstract][Full Text] [Related]
8. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
9. Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor.
Rong S; Oskarsson M; Faletto D; Tsarfaty I; Resau JH; Nakamura T; Rosen E; Hopkins RF; Vande Woude GF
Cell Growth Differ; 1993 Jul; 4(7):563-9. PubMed ID: 8398896
[TBL] [Abstract][Full Text] [Related]
10. Met receptor overexpression and oncogenic Ki-ras mutation cooperate to enhance tumorigenicity of colon cancer cells in vivo.
Long IS; Han K; Li M; Shirasawa S; Sasazuki T; Johnston M; Tsao MS
Mol Cancer Res; 2003 Mar; 1(5):393-401. PubMed ID: 12651912
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis?
Wong AS; Pelech SL; Woo MM; Yim G; Rosen B; Ehlen T; Leung PC; Auersperg N
Oncogene; 2001 Mar; 20(11):1318-28. PubMed ID: 11313876
[TBL] [Abstract][Full Text] [Related]
13. A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase.
Sattler M; Pride YB; Ma P; Gramlich JL; Chu SC; Quinnan LA; Shirazian S; Liang C; Podar K; Christensen JG; Salgia R
Cancer Res; 2003 Sep; 63(17):5462-9. PubMed ID: 14500382
[TBL] [Abstract][Full Text] [Related]
14. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
Jeffers M; Rong S; Anver M; Vande Woude GF
Oncogene; 1996 Aug; 13(4):853-6. PubMed ID: 8761307
[TBL] [Abstract][Full Text] [Related]
15. Impaired DNA double-strand break repair contributes to chemoresistance in HIF-1 alpha-deficient mouse embryonic fibroblasts.
Wirthner R; Wrann S; Balamurugan K; Wenger RH; Stiehl DP
Carcinogenesis; 2008 Dec; 29(12):2306-16. PubMed ID: 18842680
[TBL] [Abstract][Full Text] [Related]
16. Fumarate hydratase deficiency and cancer: activation of hypoxia signaling?
Ratcliffe PJ
Cancer Cell; 2007 Apr; 11(4):303-5. PubMed ID: 17418405
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
[TBL] [Abstract][Full Text] [Related]
18. Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients.
Rong S; Donehower LA; Hansen MF; Strong L; Tainsky M; Jeffers M; Resau JH; Hudson E; Tsarfaty I; Vande Woude GF
Cancer Res; 1995 May; 55(9):1963-70. PubMed ID: 7728766
[TBL] [Abstract][Full Text] [Related]
19. Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus.
Fixman ED; Naujokas MA; Rodrigues GA; Moran MF; Park M
Oncogene; 1995 Jan; 10(2):237-49. PubMed ID: 7838524
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K; Nakamura T; Sakai K; Nakamura T
Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]